Despite Biocon's assurances that the findings would not impact its business, investor sentiment appeared cautious.

The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...

Bangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection ...

Punjab National Bank: The state-run bank raised ₹ 5,000 crore via Qualified Institutions Placement (QIP). It allotted 48.19 ...

Karnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at ...

Dr. Sandeep Marwah, Chair of the Indo Ireland film and Cultural Forum under the International Chamber of media and ...

Nifty 50 has shown one of the strongest positive price seasonality. In the last 10 years, the index has closed in the green ...

IDFC First Bank, PNB, Dr Reddy's, RIL, Biocon, and More - IDFC First Bank: The board has greenlighted the merger of IDFC Financial Holding Company with ...

On August 23, 2024, the FDA approved Amgen’s aflibercept biosimilar PAVBLU (aflibercept-ayyh), a biosimilar of Regeneron’s EYLEA®. According to the approval letter, “Pavblu is indicated for ...

Benchmark NSE Nifty50 index ended down 368.11 points at 25810.85, while the BSE Sensex stood down 1272.07 points at 84299.78.

Claire's impressive academic background and contributions to oncology have been pivotal in her career. Biocon entities hold an 11% stake in Bicara post-IPO. Building Bharat’s compliance backbone: Core ...

Dividend announcements are not available. No other corporate actions details are available.